prostate cancer

You have access
Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study
NOBUTERU KUBO, HIDEMASA KAWAMURA, TAKAHIRO OIKE, HIRO SATO, MOTOTARO IWANAGA, TATSUJI MIZUKAMI, AKIKO ADACHI, HIROSHI MATSUI, KAZUTO ITO, KAZUHIRO SUZUKI and TAKASHI NAKANO

In Vivo July 2019, 33 (4) 1235-1241; DOI: https://doi.org/10.21873/invivo.11595
You have access
Early Second Round Targeted Biopsy of PI-RADS Score 3 or 4 in 256 Men With Persistent Suspicion of Prostate Cancer
PIETRO PEPE, ANTONIO GARUFI, GIAN DOMENICO PRIOLO, MICHELE PENNISI and FILIPPO FRAGGETTA

In Vivo May 2019, 33 (3) 897-901; DOI: https://doi.org/10.21873/invivo.11556
You have access
Contribution of Serum Biomarkers to Prognostic Assessment in Patients With Oligometastatic Prostate Cancer
CARSTEN NIEDER, ASTRID DALHAUG and ADAM PAWINSKI

In Vivo March 2019, 33 (2) 465-468; DOI: https://doi.org/10.21873/invivo.11495
You have access
Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an In Vivo Hen's Egg Test–Chorioallantoic Membrane Model
ARIK REUTER, AXEL SCKELL, LARS-OVE BRANDENBURG, MARTIN BURCHARDT, AXEL KRAMER and MATTHIAS B. STOPE

In Vivo January 2019, 33 (1) 41-46; DOI: https://doi.org/10.21873/invivo.11436
You have access
An Improved In Vivo Methodology to Visualise Tumour Induced Changes in Vasculature Using the Chick Chorionic Allantoic Membrane Assay
NASIDE MANGIR, AHTASHAM RAZA, JOHN W. HAYCOCK, CHRISTOPHER CHAPPLE and SHEILA MACNEIL

In Vivo May 2018, 32 (3) 461-472;
You have access
Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer
YOSHIYUKI MIYAZAWA, YOSHITAKA SEKINE, TAKAHIRO SYUTO, MASASHI NOMURA, HIDEKAZU KOIKE, HIROSHI MATSUI, YASUHIRO SHIBATA, KAZUTO ITO and KAZUHIRO SUZUKI

In Vivo March 2018, 32 (2) 409-412;
You have access
Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors
KATERINA DUSKOVA, STEPAN VESELY, JOANA DO CARMO SILVA, NATALIA CERNEI, ONDREJ ZITKA, ZBYNEK HEGER, VOJTECH ADAM, KLARA HAVLOVA and MAREK BABJUK

In Vivo March 2018, 32 (2) 425-429;
You have access
Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate Cancer
SCOTT M. GLASER, RONNY KALASH, DANTE R. BONGIORNI, MARK S. ROBERTS, GOUNDAPPA K. BALASUBRAMANI, BRUCE L. JACOBS, SUSHIL BERIWAL, DWIGHT E. HERON and JOEL S. GREENBERGER

In Vivo January 2018, 32 (1) 113-120;
You have access
Predictive Factors for Prolonged Urination Disorder After Permanent ¹²⁵I Brachytherapy for Localized Prostate Cancer
HIDEHISA MORI, TOMOHARU FUKUMORI, KEI DAIZUMOTO, MEGUMI TSUDA, YOSHIHITO KUSUHARA, TOMOYA FUKAWA, YASUYO YAMAMOTO, KUNIHISA YAMAGUCHI, MASAYUKI TAKAHASHI, AKIKO KUBO, TAKASHI KAWANAKA, SHUNSUKE FURUTANI, HITOSHI IKUSHIMA and HIRO-OMI KANAYAMA

In Vivo July 2017, 31 (4) 755-761;
You have access
Effects of Caspase 9 Gene Polymorphism in Patients with Prostate Cancer
SEDA GULEC YILMAZ, FARUK YENCILEK, ASIF YILDIRIM, ESIN YENCILEK and TURGAY ISBIR

In Vivo March 2017, 31 (2) 205-208;

Main menu

User menu

Search

prostate cancer

Pages